Form 4: Medtronic Executive Sells Shares to Cover Taxes After Vesting

Medtronic EVP & President Cardiovascular, Sean Salmon, sold 645 shares to cover taxes upon vesting of restricted stock units.

Summary

• Sean Salmon, an Executive Vice President and President of Cardiovascular at Medtronic, sold 645 ordinary shares on December 16, 2024.
• The sale was executed at a price of $82.48 per share.
• This transaction was to cover taxes due upon the vesting of restricted stock units.
• Following the transaction, Mr. Salmon beneficially owns 64,722 ordinary shares, which includes 257 shares acquired through dividend reinvestment since the last report.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment towards the company's performance or outlook.

Industry Context

Executive share sales are a common occurrence, especially around vesting periods, and are generally not indicative of a change in company outlook.

Comparison to Industry Standards

• Executive share sales for tax purposes are a standard practice across publicly traded companies.
• The number of shares sold is relatively small compared to the total shares owned by the executive, which is typical for these types of transactions.
• Similar transactions are regularly reported by executives at comparable companies such as Abbott, Boston Scientific, and Stryker.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale by an executive for tax purposes.

Key Dates

Keywords

Medtronic, MDT, Executive Share Sale, Form 4, Insider Trading, Sean Salmon, Stock Vesting, Tax Withholding, Cardiovascular